Bylvay (odevixibat)
Livdelzi (seladelpar)
Livdelzi (seladelpar) is a prescription medicine for the treatment of adults with primary biliary cholangitis (PBC). It can be used in combination with ursodeoxycholic acid (UDCA) for patients who have an inadequate response to UDCA, or as monotherapy in patients who cannot tolerate UDCA.
Livdelzi (seladelpar) is currently only approved in the USA.